معرفی
Mika Naganawa is a Research Scientist in the Department of Radiology & Biomedical Imaging at Yale School of Medicine. Her work focuses on PET imaging techniques to study synaptic density and its implications in neurodegenerative and neuropsychiatric disorders. She holds a PhD from the University of Tokyo (2004) and has extensive postdoctoral experience at institutions like the National Institute of Radiological Sciences and Tokyo Metropolitan Institute of Gerontology.
Her research interests include biomedical engineering, dementia, pharmacokinetics, and substance-related disorders. She has pioneered studies using PET tracers like [11C]UCB-J and [18F]SynVesT-1 to quantify synaptic density in conditions such as Alzheimer’s disease, Parkinson’s disease, and autism. Her work bridges clinical neuroscience with advanced imaging technologies, contributing to understanding disease mechanisms and therapeutic targets.
Publications highlight her expertise in PET quantification methods, motion correction algorithms, and translational applications of imaging biomarkers. Collaborations with global teams (e.g., NIH, European institutions) underscore her role in interdisciplinary research.
